Literature DB >> 17471120

Actual practices in nephropathology: a survey and comparison with best practices.

James M Pullman1, Franco Ferrario, Cynthia C Nast.   

Abstract

Nephropathology is a specialized field requiring routine tissue evaluation by immunofluorescence (IF), electron microscopy (EM), and light microscopy, and has published standards of best practice. Actual practices are less well documented. We therefore evaluated actual practices in nephropathology and their divergence from best practices. One hundred and twenty Renal Pathology Society members were given questionnaires regarding tissue handling, processing, and staining. Appropriate statistics for each question were calculated from results compiled into Microsoft Excel. Responses from 75 members showed that most received 16 or 18 gauge core biopsies, examined 9 slides for native kidneys, 8 slides for transplant kidneys, and for both used hematoxylin and eosin, periodic acid-Schiff, trichrome, and silver stains. For native kidney biopsies, most collected for IF and EM if tissue was adequate, while clinical input could influence the rest. Almost all performed IF on adequate samples, with a minimum of 8 antibodies, including both light chains, those from Europe sometimes without proof of adequacy. Half performed EM unconditionally, the remainder based on specimen adequacy or clinical input. For transplant kidney biopsies, most collected tissue for IF and EM only with specific clinical indications, performed C4d IF on frozen tissue if available, but few used the native kidney IF panel. Very few performed EM unconditionally, but most would if given specific indications. We conclude that actual nephropathology practices within the Renal Pathology Society are geographically uniform and similar to published best practices, with divergence in performing IF and EM on the basis of specimen adequacy and clinical input, particularly in transplant biopsies.

Entities:  

Mesh:

Year:  2007        PMID: 17471120     DOI: 10.1097/PAP.0b013e31803250d8

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  7 in total

1.  Paraffin immunofluorescence in the renal pathology laboratory: more than a salvage technique.

Authors:  Nidia C Messias; Patrick D Walker; Christopher P Larsen
Journal:  Mod Pathol       Date:  2015-02-13       Impact factor: 7.842

Review 2.  The renal biopsy in the genomic era.

Authors:  Helen Liapis; Joseph P Gaut
Journal:  Pediatr Nephrol       Date:  2012-11-21       Impact factor: 3.714

3.  Characteristics of patients with coexisting DNAJB9-associated fibrillary glomerulonephritis and IgA nephropathy.

Authors:  Samar M Said; Alejandro Best Rocha; Anthony M Valeri; Mohamad Sandid; Anhisekh Sinha Ray; Mary E Fidler; Mariam Priya Alexander; Christopher P Larsen; Samih H Nasr
Journal:  Clin Kidney J       Date:  2020-12-05

4.  Two-Week Protocol Biopsy in Renal Allograft: Feasibility, Safety, and Outcomes.

Authors:  Manuel Lim; Byung Kwan Park; Kyo Won Lee; Jae Berm Park; Kyeong Deok Kim; Jaehun Yang; Jieun Kwon; Eun Sung Jeong; Seunghwan Lee
Journal:  J Clin Med       Date:  2022-01-31       Impact factor: 4.241

5.  Sometimes when you hear hoof beats, it could be a zebra: consider the diagnosis of Fabry disease.

Authors:  James O Burton; John P Dormer; Helen E Binns; Warren P Pickering
Journal:  BMC Nephrol       Date:  2012-07-31       Impact factor: 2.388

6.  DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis.

Authors:  Samih H Nasr; Julie A Vrana; Surendra Dasari; Frank Bridoux; Mary E Fidler; Sihem Kaaki; Nathalie Quellard; Alexia Rinsant; Jean Michel Goujon; Sanjeev Sethi; Fernando C Fervenza; Lynn D Cornell; Samar M Said; Ellen D McPhail; Loren P Herrera Hernandez; Joseph P Grande; Marie C Hogan; John C Lieske; Nelson Leung; Paul J Kurtin; Mariam P Alexander
Journal:  Kidney Int Rep       Date:  2017-08-08

Review 7.  Paraffin Immunofluorescence: A Valuable Ancillary Technique in Renal Pathology.

Authors:  Samih H Nasr; Mary E Fidler; Samar M Said
Journal:  Kidney Int Rep       Date:  2018-07-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.